Spondyloarthritis & psoriatic arthritis
Evaluating remission and low disease activity from the perspective of the patient with axial spondyloarthritis: The cross-sectional ConREspAx study
Authors' conclusion
In a real-life setting, the evaluation of remission by the patient through a single question was the hardest criterion to achieve, although it did prove to be a feasible, valid, and specific way to assess remission.
Study context
- Population
- Consecutive patients with axSpA fulfilling ASAS criteria, single tertiary care hospital63.8% males
- Participants
- 105 patients
- Exposure
- Patient's single-question perception of remission and low disease activity (LDA) vs physician's perception and current definitions of remission and LDA
- Outcome
- Agreement (PABAK) between patients' single-question perception of remission/LDA and current definitions; sensitivity and specificity of current definitions vs patient perception as gold standard
Methodological detailssingle-centre, tertiary care hospital, consecutive inclusion
- Single-centre
- Tertiary care hospital
- Consecutive inclusion
Main finding
As reported in the abstract
Remission
LDA
- Best agreement with patients' perceived remission: BASDAI < 2 and normal CRP; sensitivity
- 72.7%
- BASDAI < 2 and normal CRP vs patient's perception as gold standard; specificity
- 83.1%
Observational data: associations, not effects.
Original publication
Evaluating remission and low disease activity from the perspective of the patient with axial spondyloarthritis: The cross-sectional ConREspAx study. Joint Bone Spine. Published 7 December 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →